share_log

Short Interest in Yellow Cake Plc (OTCMKTS:YLLXF) Expands By 30.4%

Defense World ·  Feb 14, 2023 03:32

Yellow Cake plc (OTCMKTS:YLLXF – Get Rating) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 554,100 shares, an increase of 30.4% from the January 15th total of 424,900 shares. Based on an average daily trading volume, of 17,800 shares, the days-to-cover ratio is currently 31.1 days.

Yellow Cake Stock Performance

YLLXF opened at $5.35 on Tuesday. The business has a 50 day moving average of $4.80 and a 200-day moving average of $4.74. Yellow Cake has a 52 week low of $3.75 and a 52 week high of $6.60.

Get Yellow Cake alerts:

Analyst Upgrades and Downgrades

Separately, Berenberg Bank increased their price objective on Yellow Cake from GBX 543 ($6.59) to GBX 552 ($6.70) in a report on Thursday, February 9th.

Yellow Cake Company Profile

(Get Rating)

Yellow Cake plc, a specialist company, operates in the uranium sector. It is involved in the purchase and holding of uranium oxide concentrates; and exploitation of other uranium-related opportunities. The company was incorporated in 2018 and is headquartered in Saint Helier, Jersey.

Further Reading

  • Get a free copy of the StockNews.com research report on Yellow Cake (YLLXF)
  • Should Medtronic's Recent Colibri Patent Controversy Concern You?
  • Checkpoint Software Helps Cyber Security Stocks Bottom
  • Under Armour Stock, Gap and Crap, Here's Why
  • Is Chevron Positioned To Take Energy Sector Leadership?
  • What Does the Consumer Price Index Measure?

Receive News & Ratings for Yellow Cake Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yellow Cake and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment